Global Intravenous Immunoglobulin (IVIg) Market Growth 2022-2028
As the global economy mends, the 2021 growth of Intravenous Immunoglobulin (IVIg) will have significant change from previous year. According to our latest study, the global Intravenous Immunoglobulin (IVIg) market size is USD million in 2022 from USD 10090 million in 2021, with a change of % between 2021 and 2022. The global Intravenous Immunoglobulin (IVIg) market size will reach USD 15290 million in 2028, growing at a CAGR of 6.1% over the analysis period.
The United States Intravenous Immunoglobulin (IVIg) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Intravenous Immunoglobulin (IVIg) market, reaching US$ million by the year 2028. As for the Europe Intravenous Immunoglobulin (IVIg) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Intravenous Immunoglobulin (IVIg) players cover Baxter, Grifols, CSL, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin (IVIg) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
IVIg Liquid
IVIg Powder
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravenous Immunoglobulin (IVIg) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravenous Immunoglobulin (IVIg) by Country/Region, 2017, 2022 & 2028
2.2 Intravenous Immunoglobulin (IVIg) Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Intravenous Immunoglobulin (IVIg) Sales by Type
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2022)
2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2017-2022)
2.4 Intravenous Immunoglobulin (IVIg) Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Intravenous Immunoglobulin (IVIg) Sales by Application
2.5.1 Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2017-2022)
2.5.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2017-2022)
3 Global Intravenous Immunoglobulin (IVIg) by Company
3.1 Global Intravenous Immunoglobulin (IVIg) Breakdown Data by Company
3.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Company (2020-2022)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2020-2022)
3.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Company (2020-2022)
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2022)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2020-2022)
3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Company
3.4 Key Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Location Distribution
3.4.2 Players Intravenous Immunoglobulin (IVIg) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intravenous Immunoglobulin (IVIg) by Geographic Region
4.1 World Historic Intravenous Immunoglobulin (IVIg) Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Geographic Region
4.2 World Historic Intravenous Immunoglobulin (IVIg) Market Size by Country/Region (2017-2022)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Country/Region
4.3 Americas Intravenous Immunoglobulin (IVIg) Sales Growth
4.4 APAC Intravenous Immunoglobulin (IVIg) Sales Growth
4.5 Europe Intravenous Immunoglobulin (IVIg) Sales Growth
4.6 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Growth
5 Americas
5.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country
5.1.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022)
5.1.2 Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022)
5.2 Americas Intravenous Immunoglobulin (IVIg) Sales by Type
5.3 Americas Intravenous Immunoglobulin (IVIg) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region
6.1.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2022)
6.1.2 APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2022)
6.2 APAC Intravenous Immunoglobulin (IVIg) Sales by Type
6.3 APAC Intravenous Immunoglobulin (IVIg) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravenous Immunoglobulin (IVIg) by Country
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022)
7.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Type
7.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) by Country
8.1.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type
8.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin (IVIg)
10.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
10.4 Industry Chain Structure of Intravenous Immunoglobulin (IVIg)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Immunoglobulin (IVIg) Distributors
11.3 Intravenous Immunoglobulin (IVIg) Customer
12 World Forecast Review for Intravenous Immunoglobulin (IVIg) by Geographic Region
12.1 Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Region
12.1.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Region (2023-2028)
12.1.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous Immunoglobulin (IVIg) Forecast by Type
12.7 Global Intravenous Immunoglobulin (IVIg) Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Offered
13.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Intravenous Immunoglobulin (IVIg) Product Offered
13.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Intravenous Immunoglobulin (IVIg) Product Offered
13.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Offered
13.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Biotest
13.5.1 Biotest Company Information
13.5.2 Biotest Intravenous Immunoglobulin (IVIg) Product Offered
13.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biotest Main Business Overview
13.5.5 Biotest Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Offered
13.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Offered
13.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Intravenous Immunoglobulin (IVIg) Product Offered
13.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Offered
13.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Offered
13.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 LFB Group
13.11.1 LFB Group Company Information
13.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Offered
13.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 LFB Group Main Business Overview
13.11.5 LFB Group Latest Developments
13.12 BPL
13.12.1 BPL Company Information
13.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Offered
13.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 BPL Main Business Overview
13.12.5 BPL Latest Developments
13.13 Sichuan Yuanda Shuyang
13.13.1 Sichuan Yuanda Shuyang Company Information
13.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Offered
13.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Sichuan Yuanda Shuyang Main Business Overview
13.13.5 Sichuan Yuanda Shuyang Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Intravenous Immunoglobulin (IVIg) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intravenous Immunoglobulin (IVIg) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of IVIg Liquid
Table 4. Major Players of IVIg Powder
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2022)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2022)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2017-2022) & (USD/Bottle)
Table 10. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 11. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2022)
Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022)
Table 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2022)
Table 14. Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2017-2022) & (USD/Bottle)
Table 15. Global Intravenous Immunoglobulin (IVIg) Sales by Company (2020-2022) & (K Bottle)
Table 16. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2020-2022)
Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2020-2022)
Table 19. Global Intravenous Immunoglobulin (IVIg) Sale Price by Company (2020-2022) & (USD/Bottle)
Table 20. Key Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution and Sales Area
Table 21. Players Intravenous Immunoglobulin (IVIg) Products Offered
Table 22. Intravenous Immunoglobulin (IVIg) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Intravenous Immunoglobulin (IVIg) Sales by Geographic Region (2017-2022) & (K Bottle)
Table 26. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Intravenous Immunoglobulin (IVIg) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Intravenous Immunoglobulin (IVIg) Sales by Country/Region (2017-2022) & (K Bottle)
Table 30. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Intravenous Immunoglobulin (IVIg) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
Table 34. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2017-2022)
Table 35. Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2017-2022)
Table 37. Americas Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 38. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2022)
Table 39. Americas Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 40. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2022)
Table 41. APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2022) & (K Bottle)
Table 42. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2017-2022)
Table 43. APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2017-2022)
Table 45. APAC Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 46. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2022)
Table 47. APAC Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 48. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2022)
Table 49. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
Table 50. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2017-2022)
Table 51. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2017-2022)
Table 53. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 54. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2022)
Table 55. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 56. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
Table 58. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 62. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 64. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Intravenous Immunoglobulin (IVIg)
Table 66. Key Market Challenges & Risks of Intravenous Immunoglobulin (IVIg)
Table 67. Key Industry Trends of Intravenous Immunoglobulin (IVIg)
Table 68. Intravenous Immunoglobulin (IVIg) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Intravenous Immunoglobulin (IVIg) Distributors List
Table 71. Intravenous Immunoglobulin (IVIg) Customer List
Table 72. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2023-2028) & (K Bottle)
Table 73. Global Intravenous Immunoglobulin (IVIg) Sales Market Forecast by Region
Table 74. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2023-2028) & (K Bottle)
Table 77. Americas Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2023-2028) & (K Bottle)
Table 79. APAC Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2023-2028) & (K Bottle)
Table 81. Europe Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2023-2028) & (K Bottle)
Table 83. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2023-2028) & (K Bottle)
Table 85. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2023-2028) & (K Bottle)
Table 89. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Baxter Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 93. Baxter Intravenous Immunoglobulin (IVIg) Product Offered
Table 94. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 95. Baxter Main Business
Table 96. Baxter Latest Developments
Table 97. Grifols Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Intravenous Immunoglobulin (IVIg) Product Offered
Table 99. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. CSL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Intravenous Immunoglobulin (IVIg) Product Offered
Table 104. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 105. CSL Main Business
Table 106. CSL Latest Developments
Table 107. Octapharma Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 108. Octapharma Intravenous Immunoglobulin (IVIg) Product Offered
Table 109. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 110. Octapharma Main Business
Table 111. Octapharma Latest Developments
Table 112. Biotest Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 113. Biotest Intravenous Immunoglobulin (IVIg) Product Offered
Table 114. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 115. Biotest Main Business
Table 116. Biotest Latest Developments
Table 117. Kedrion Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 118. Kedrion Intravenous Immunoglobulin (IVIg) Product Offered
Table 119. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 120. Kedrion Main Business
Table 121. Kedrion Latest Developments
Table 122. Hualan Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 123. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Offered
Table 124. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 125. Hualan Bio Main Business
Table 126. Hualan Bio Latest Developments
Table 127. CNBG Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 128. CNBG Intravenous Immunoglobulin (IVIg) Product Offered
Table 129. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 130. CNBG Main Business
Table 131. CNBG Latest Developments
Table 132. Shanghai RAAS Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Offered
Table 134. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 135. Shanghai RAAS Main Business
Table 136. Shanghai RAAS Latest Developments
Table 137. CBPO Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 138. CBPO Intravenous Immunoglobulin (IVIg) Product Offered
Table 139. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 140. CBPO Main Business
Table 141. CBPO Latest Developments
Table 142. LFB Group Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 143. LFB Group Intravenous Immunoglobulin (IVIg) Product Offered
Table 144. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 145. LFB Group Main Business
Table 146. LFB Group Latest Developments
Table 147. BPL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 148. BPL Intravenous Immunoglobulin (IVIg) Product Offered
Table 149. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 150. BPL Main Business
Table 151. BPL Latest Developments
Table 152. Sichuan Yuanda Shuyang Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 153. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Offered
Table 154. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 155. Sichuan Yuanda Shuyang Main Business
Table 156. Sichuan Yuanda Shuyang Latest Developments
List of Figures
Figure 1. Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2017-2028 (K Bottle)
Figure 7. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intravenous Immunoglobulin (IVIg) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of IVIg Liquid
Figure 10. Product Picture of IVIg Powder
Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2021
Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2022)
Figure 13. Intravenous Immunoglobulin (IVIg) Consumed in Immunodeficiency
Figure 14. Global Intravenous Immunoglobulin (IVIg) Market: Immunodeficiency (2017-2022) & (K Bottle)
Figure 15. Intravenous Immunoglobulin (IVIg) Consumed in Autoimmune Disease
Figure 16. Global Intravenous Immunoglobulin (IVIg) Market: Autoimmune Disease (2017-2022) & (K Bottle)
Figure 17. Intravenous Immunoglobulin (IVIg) Consumed in Acute Infection
Figure 18. Global Intravenous Immunoglobulin (IVIg) Market: Acute Infection (2017-2022) & (K Bottle)
Figure 19. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2022)
Figure 20. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application in 2021
Figure 21. Intravenous Immunoglobulin (IVIg) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company in 2021
Figure 23. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Geographic Region in 2021
Figure 25. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2017-2022)
Figure 26. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country/Region in 2021
Figure 27. Americas Intravenous Immunoglobulin (IVIg) Sales 2017-2022 (K Bottle)
Figure 28. Americas Intravenous Immunoglobulin (IVIg) Revenue 2017-2022 ($ Millions)
Figure 29. APAC Intravenous Immunoglobulin (IVIg) Sales 2017-2022 (K Bottle)
Figure 30. APAC Intravenous Immunoglobulin (IVIg) Revenue 2017-2022 ($ Millions)
Figure 31. Europe Intravenous Immunoglobulin (IVIg) Sales 2017-2022 (K Bottle)
Figure 32. Europe Intravenous Immunoglobulin (IVIg) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales 2017-2022 (K Bottle)
Figure 34. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue 2017-2022 ($ Millions)
Figure 35. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2021
Figure 36. Americas Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2021
Figure 37. United States Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2021
Figure 42. APAC Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions in 2021
Figure 43. China Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2021
Figure 50. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2021
Figure 51. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2021
Figure 58. Egypt Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Intravenous Immunoglobulin (IVIg) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin (IVIg) in 2021
Figure 64. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 65. Industry Chain Structure of Intravenous Immunoglobulin (IVIg)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
